Tuberculosis (TB)

Country data by WHO Region


Africa: country data

Cape Verde

The NTP notes that age and sex data are incomplete.

Ethiopia

The NTP notes that treatment outcome data are provisional.

Gabon

Selected data received in non- standard format. DOTS coverage was assumed to be same as in the previous report.

Kenya

The treatment outcome cohort excludes nomadic patients (roughly 10% of patients registered) who are not evaluated at the end of their treatment regimen.

Madagascar

Data are considered preliminary (83% of expected quarterly reports received). Treatment success for a subset of 11 214 patients on short-course chemotherapy was 74% (with 15% defaulting). Treatment success for a subset of 69 patients on long-course chemotherapy was 67% (with 23% defaulting).

Mali

Some 100 patients classified and registered as new smear-positive were excluded from the cohort analysis of treatment outcomes after a chart audit revealed that the initial smear result for these patients could not be identified.

Mozambique

Age and sex data are not available according to the categories requested. Among smear-positive cases in 2003, 1.9% were in children. Aside from DOTS coverage, an estimate of “access” to TB services is reportedly 57%.

Seychelles

DOTS coverage was not reported, but assumed to be same as in the previous report.

South Africa

Data on age and sex of new smear-positive cases are available as follows:

Age (years) Male Female

0–14 38 36

15–19 115 132

20–39 1 143 837

40–59 549 359

60+ 81 49

Swaziland

The NTP notes that age and sex data are incomplete.

Uganda

The NTP notes that age and sex data are incomplete.

United Republic of Tanzania

Aside from DOTS coverage, an estimate of “access” is reported in terms of distance from health facility: 70% of the population lives with 5 km from a health unit, and 90% lives within 10 km from a health unit.

Share